# The Biologic Excipients Market is expected to be valued at US$ 1,706.2 million by the end of 2028 | FMI
Published: 2021-10-06
Category: Research Reports
Category URL: https://palmbayherald.com/category/research-reports/
Meta Title: Global Biologic Excipients Market: Segmental Analysis &
Meta Description: Get detailed insights on the global biologic excipients market, including segmental analysis, forecasts, dynamics, and regional analysis, in the upcoming report
URL: https://palmbayherald.com/the-biologic-excipients-market-is-expected-to-be-valued-at-us-1706-2-million-by-the-end-of-2028-fmi/

Future Market Insights (FMI) delivers key insights on the global [biologic](https://palmbayherald.com/psoriasis-treatment-market-surges-to-usd-48-09-billion-by-2031-propelled-by-8-7-cagr-verified-market-research/) excipients market in its upcoming report titled “ [Biologic Excipients Market](https://www.futuremarketinsights.com/reports/biologic-excipients-market): Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this [report.](https://palmbayherald.com/china-africa-relationship-at-its-strongest-says-new-report-ahead-of-8th-forum-on-china-africa-cooperation/)

**Global Biologic Excipients Market: Segmental Analysis & Forecast**

The global market is segmented based on excipient type, end user and region. Based on excipient type the market is segmented into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and others. Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period.

By end user, the market is segmented into biopharmaceutical manufacturers, contract research organisations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers is the leading segment in the global [biologic](https://palmbayherald.com/psoriasis-treatment-market-surges-to-usd-48-09-billion-by-2031-propelled-by-8-7-cagr-verified-market-research/) excipients market over the forecast period. This segment accounts for a relatively higher revenue share, which is expected to register a CAGR of 6.0% over the forecast period.

**Get Report Sample Copy @** [**https://www.futuremarketinsights.com/reports/sample/rep-gb-6982**](https://www.futuremarketinsights.com/reports/sample/rep-gb-6982)

**Global Biologic Excipients Market: Dynamics**

Growth of the global biologic excipients market is primarily driven by rising global demand for medicines, greater uptake of biologics driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in pediatric formulations, growing demand for extended-release or sustained release formulations, increasing demand for oral solid drug formulations, rising demand from emerging economies pushing local drug production, and increasing per capita healthcare expenditure.

However, lack of proper data documentation on gras status of excipients, regulatory audits restricting supply capacity, regulatory hurdles detering novel excipient development, and stability testing of excipients imposing cost liabilities on drug manufacturers are some factors expected to hamper the growth of the global biologic excipients [market](https://palmbayherald.com/gum-content-tester-market-2021-scope-of-current-and-future-industry-2029/) over the forecast period.

A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. Furthermore, the growing importance of developing biologic excipients by big players in order to enhance their product portfolio, growing importance for manufacturing authorisation, growing market for topical and parenteral applications and compulsory licensing promoting demand for [biologic](https://palmbayherald.com/psoriasis-treatment-market-surges-to-usd-48-09-billion-by-2031-propelled-by-8-7-cagr-verified-market-research/) excipients are the key trends likely to be witnessed in the global biologic excipients market.

![global biologic excipients market](https://prod.superblogcdn.com/site_cuid_cm5qsn97w0023wirgsdl4dy79/images/global-biologic-excipients-market-1737031743963-compressed.jpg)

**Global Biologic Excipients Market: Regional Analysis**

The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.

Some of the key players featured in this [report](https://palmbayherald.com/china-africa-relationship-at-its-strongest-says-new-report-ahead-of-8th-forum-on-china-africa-cooperation/) on the global biologic excipients market include BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd. This report discusses the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

**Speak To Analyst For Queries about Report @** [**https://www.futuremarketinsights.com/ask-question/rep-gb-6982**](https://www.futuremarketinsights.com/ask-question/rep-gb-6982)

**Reasons to Buy the report**

- We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
- Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
- The report includes accurate analysis of the [market](https://palmbayherald.com/gum-content-tester-market-2021-scope-of-current-and-future-industry-2029/) and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

**Explore Wide-ranging Coverage of FMI’s** **Healthcare** **Market Insights Landscape**

- [Pharmaceuticals Excipients Market](https://www.futuremarketinsights.com/reports/pharmaceuticals-excipients-market)
- [Sustained Release Excipients Market](https://www.futuremarketinsights.com/reports/sustained-release-excipients-market)
- Biologic Response Modifiers Market

**About FMI**

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

**Contact**

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: [sales@futuremarketinsights.com](mailto:sales@futuremarketinsights.com)

For Media Enquiries: [press@futuremarketinsights.com](mailto:press@futuremarketinsights.com)

**Press Release:** [**https://www.futuremarketinsights.com/press-release/biologic-excipients-market**](https://www.futuremarketinsights.com/press-release/biologic-excipients-market)

The post [The Biologic Excipients Market is expected to be valued at US$ 1,706.2 million by the end of 2028 \| FMI](https://industrynewsanalysis.com/the-biologic-excipients-market-is-expected-to-be-valued-at-us-1706-2-million-by-the-end-of-2028-fmi/) appeared first on [Industry News Analsis](https://industrynewsanalysis.com).


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---